Awards & Advancement

ICON announces senior appointments

Monday, October 17, 2016

ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has announced senior appointments to its clinical research, medical imaging and commercialization and outcomes services. Dr. Andrew Garrett has been appointed executive vice president, Scientific Operations, Dr. Paul McCracken has joined ICON as vice president, Medical Imaging and Jim Carroll has been appointed vice president, Real World Evidence (RWE).

[Read More]

CAR-T expert Li Zhou added to TxCell’s staff

Friday, October 14, 2016

TxCell, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, has appointed Li Zhou, Ph.D., vice president, Cell Engineering. Dr. Zhou brings extensive pharmaceutical experience in antibody engineering and T-cell engineering to strengthen and accelerate the development of TxCell’s ENTrIA CAR-Treg platform.

[Read More]

SynteractHCR hires three to international leadership team

Wednesday, October 12, 2016

SynteractHCR, a full-service, international CRO, has appointed three new senior-level managers to strengthen its leadership team internationally. The new hires include Linda Rawlings as executive director strategic development, Pascale Goujard-Paquette as senior director of clinical operations in the EU, and Erin Parker as senior director of global medical operations. These three professionals have had extensive experience in clinical research delivery at a local, international and global level, and across a myriad of therapeutic areas.

[Read More]

International Biomedical Research Alliance appoints Jeffrey I. Auerbach to board

Tuesday, October 11, 2016

The International Biomedical Research Alliance, a nonprofit organization which provides programming and funding support for the NIH Oxford-Cambridge Scholars Program, has announced that Jeffrey I. Auerbach, Ph.D., is joining the Alliance’s board of directors. Dr. Auerbach is the founder and managing member of AuerbachSchrot, an intellectual property (IP) law firm based in Rockville, Md.

[Read More]

AHA, Verily, AstraZeneca announce One Brave Idea Research Award Winner

Tuesday, October 11, 2016

The American Heart Association (AHA), Verily Life Sciences (formerly Google Life Sciences), an Alphabet company, and AstraZeneca, have announced that the One Brave Idea research award will be granted to Dr. Calum MacRae, chief of Cardiovascular Medicine at Boston’s Brigham and Women’s Hospital, to support his visionary approach to understanding and addressing coronary heart disease (CHD) and its devastating consequences.

[Read More]

Schulman IRB’s Central Oncology Review Division adds Judith Carrithers

Tuesday, October 4, 2016

Schulman IRB, a central IRB in customer service and technology, announced that Judith Carrithers, JD, MPA, will join its Central Oncology Review (COR) division October 15, 2016, as director of Oncology Services. Launching later in 2016, COR will provide collaborative, flexible IRB review services for oncology research centers seeking a more advanced level of partnership and service integration from a central IRB. [Read More]

CRF Health appoints Jamie Moss chief operating officer

Wednesday, September 28, 2016

CRF Health, a global provider of eCOA solutions for the life sciences industry, announced the appointment of Jamie Moss as chief operating officer (COO), assuming responsibility for CRF Health’s global operations. The company has enjoyed significant growth and continued investment in the eCOA space having recently acquired mHealth provider, Entra Health. This appointment continues to place an emphasis on ensuring quality and scalable operational delivery to meet growing customer demand.

[Read More]